Abstract
Background: Systemic sclerosis (SSc) is a systemic autoimmune disease characterized by microangiopathy, inflammation, fibrosis. Interstitial lung disease (ILD) is common among SSc patients.
Objective: This study aims to define the clinical, laboratory, and serologic characteristics of SSc patients with ILD and to present the frequency of chest computed tomography features.
Methods: Two hundred twenty-six SSc patients who applied to the Rheumatology Department between January 2007 and August 2019 were retrospectively examined. A total of 100 SSc patients with ILD (44.2%) were determined. Clinical, laboratory, and serological features of SSc patients with and without ILD were compared.
Result: Both groups had similar characteristics in terms of age and sex. The duration of disease (p=0.001) and follow-up time (p=0.001) were longer in SSc patients with ILD. Multivariable logistic regression analysis indicated that the duration of disease (OR: 1.06 (1.01-1.13), p=0.029), presence of gastrointestinal system involvement (OR: 3.29 (1.28-8.46), p=0.013) and anti-SCL70-positivity (OR: 6.04 (2.35-15.49), p <0.001) were associated with ILD. There was an inverse relationship between Anti-CENP-B positivity and the presence of ILD (p=0.001). The assessment regarding the chest computed tomography characteristics of interstitial pneumonia patterns were as follows: 82.5% non-specific interstitial pneumonia, 14.4% usual interstitial pneumonia, and 2.1% desquamative interstitial pneumonia. The most frequent abnormal findings included ground-glass opacification (88.7%), reticulation (64.9%), traction bronchiectasis (57.7%), septal thickening (52.6%) and honeycombing (28.9%).
Conclusion: We have shown a relationship between anti-SCL70, disease duration, gastrointestinal system involvement, and ILD in SSc patients.
Keywords: Systemic sclerosis, interstitial lung disease, pulmonary fibrosis, mortality, anti-SCL70, anti-CENP-B.
[http://dx.doi.org/10.1016/S0140-6736(17)30933-9] [PMID: 28413064]
[http://dx.doi.org/10.1007/s00296-016-3636-7] [PMID: 28063071]
[PMID: 26949346]
[http://dx.doi.org/10.1002/acr.21583] [PMID: 22213733]
[http://dx.doi.org/10.1084/jem.20110551] [PMID: 21727191]
[http://dx.doi.org/10.1002/art.38098] [PMID: 24122180]
[PMID: 11469464]
[http://dx.doi.org/10.1183/09031936.00060209] [PMID: 19541715]
[http://dx.doi.org/10.1002/art.38390] [PMID: 24591477]
[http://dx.doi.org/10.3109/14397595.2015.1115455] [PMID: 26561397]
[PMID: 9002015]
[http://dx.doi.org/10.1136/ard.2006.062901] [PMID: 17234652]
[http://dx.doi.org/10.3389/fimmu.2015.00167] [PMID: 25926833]
[http://dx.doi.org/10.1002/art.21646] [PMID: 16508979]
[http://dx.doi.org/10.5606/ArchRheumatol.2018.6630] [PMID: 30632529]
[http://dx.doi.org/10.4236/ojra.2013.32017]
[http://dx.doi.org/10.1164/ajrccm.158.6.9804105] [PMID: 9847271]
[http://dx.doi.org/10.1378/chest.123.6.1932] [PMID: 12796170]
[http://dx.doi.org/10.1002/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L] [PMID: 11501722]
[http://dx.doi.org/10.7326/0003-4819-121-1-199407010-00002] [PMID: 8198350]
[PMID: 9149182]
[http://dx.doi.org/10.1016/j.semarthrit.2017.03.019] [PMID: 28454677]
[http://dx.doi.org/10.1007/s00296-017-3893-0] [PMID: 29185086]
[http://dx.doi.org/10.1002/art.22532] [PMID: 17330281]
[http://dx.doi.org/10.1371/journal.pone.0163894] [PMID: 27706206]
[http://dx.doi.org/10.1136/annrheumdis-2018-213201] [PMID: 29875097]
[http://dx.doi.org/10.1007/s00296-017-3916-x] [PMID: 29322341]
[http://dx.doi.org/10.1378/chest.07-2444] [PMID: 18641099]
[http://dx.doi.org/10.1016/j.lpm.2014.08.002] [PMID: 25217474]
![Wayfinder Image](/images/wayfinder.jpg)